Webinar – Use Basophils as Biomarker for Potency and Efficacy of Drugs in Development with Flow CAST® Inhibitors of PI3K and BTK pathways are a large focus for pharmaceutical companies with several small molecule inhibitors currently at different stages of development. Enzymatic assays to measure the direct activity of compounds are available in the market
Social Links